FC
MRTX

Finepoint Capital’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Finepoint Capital’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-210,200
Closed -$14.1M – 61
2022
Q2 		$14.1M Buy
+210,200
New +$14.1M 4.88% 12